
|Articles|April 1, 1998
Supplements and Featured Publications
- Clinical and Economic Considerations of Helicobacter pylori Eradication and Screening
- Volume 4
- Issue 5 Suppl
Is Curing Peptic Ulcer Disease an Oxymoron? A Focus on Helicobacter pylori
Author(s)William R. Garnett, PharmD
Advertisement
Articles in this issue
over 27 years ago
Participating Facultyover 27 years ago
The Impact of H Pylori Eradication on Your Pharmacy Budgetover 27 years ago
Overview of H pylori in Peptic Ulcer Diseaseover 27 years ago
Clinical Issues and Cost Effectiveness of Treating H pyloriover 27 years ago
Current Issues in H pylori Eradicationover 27 years ago
CPE Quizover 27 years ago
Selected Abstractsover 27 years ago
BibliographyNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Fixed-Duration Epcoritamab Plus Chemotherapy Yields Response, Remissions in DLBCL
2
EPCORE FL-1: Adding Epcoritamab to R2 Delivers “New Benchmark” in Second-Line Follicular Lymphoma
3
In CLL, Fixed-Duration Venetoclax Combos Are Equal to Continuous Ibrutinib in Head-to-Head Comparison
4
ASH 2025 Offers Data That Could Make Novel Therapies More Accessible
5














































